Brief news reports on Tuberculosis

UK and Indian researchers unite to fight global TB epidemic

University of Birmingham academics from the School of Biosciences are joining forces with peers from the Indian Institute of Science, Bangalore (IISc) in a new research partnership focused on tackling tuberculosis (TB).

Read More →

TB and drug resistant TB in South Africa

South Africa is currently burdened with one of the world’s worst Tuberculosis (TB) epidemics, despite its relative wealth, strong health care system, and commitment to combating the disease. Within a population of 50 million, approximately 400,000 new cases are reported each year (World Health Organization (WHO), 2011). 

Read More →

Global Fund explains “Transitional Funding Mechanism”

The Global Fund to Fight AIDS, Tuberculosis and Malaria released an “Information Note” explaining the Transitional Funding Mechanism (TFM) that the Fund Board recently decided would replace a Round 11 funding cycle. The information note and accompanying documentation are meant to aid applicants in the development of proposals for TFM funding.

Read More →

Tuberculosis infection - pipeline assessment and market forecasts to 2018

Research and Markets ( has announced the addition of GlobalData's new report "Tuberculosis Infection - Pipeline Assessment and Market Forecasts to 2018" to their offering.

Read More →

Lesotho: MCC fights AIDS and tuberculosis in Lesotho

Washington — The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems.

Read More →

Danish researchers discover new drug to fight multi-resistant bacteria

Danish researchers said Friday they have invented a new drug that can be used to cure such diseases as multi-resistant staphylococcus, resistant tuberculosis and resistant salmonella-typhus.

Read More →

CDC issues new TB treatment guidelines

They're aimed at shortening, simplifying the regimen used to prevent active disease. The new guidelines apply only to the United States.

Read More →

Short-term TB combination as successful as isoniazid therapy

Weekly rifapentine plus isoniazid given under direct supervision for 3 months was as effective in preventing tuberculosis (TB) as 9 months of daily self-administered isoniazid, according to a report published in the December 8 issue of the New England Journal of Medicine.

Read More →

Scientists to develop new drug to treat tuberculosis

Scientists at the University of Liverpool and the Liverpool School of Tropical Medicine have begun work on a £1 million project to design a new drug for the treatment of tuberculosis (TB).

Read More →

UK: TB diagnosis is increased in postpartum women

The incidence of tuberculosis (TB) diagnosis is significantly increased in mothers postpartum, suggesting a potential new population to target for screening, according to a new UK-wide cohort study.

Read More →

Page 585 of 611 · Total posts: 10

←First 584 585 586 Last→